Replies to post #168561 on Biotech Values

[jq1234]

Look like another GNBT. Are these companies really out of their minds? In its release titled:

Osiris Legal Team Responds to False and Misleading Story by TheStreet.com

It said:

The correspondence to which the story referred was an “Untitled Letter” which FDA uses as a mechanism for initial correspondence that does not meet the standard for regulatory significance.

http://finance.yahoo.com/news/osiris-legal-team-responds-false-190000372.html

If it weren't to "meet the standard for regulatory significance", why would they release PR this morning titled:

Osiris and FDA Reach Agreement on Regulatory Pathway for Biosurgery Products

http://finance.yahoo.com/news/osiris-fda-reach-agreement-regulatory-130000397.html

[DewDiligence]

OSIR CEO leaving for “personal reasons”:

http://finance.yahoo.com/news/osiris-therapeutics-announces-leadership-transition-213000799.html